Canada • TSX Venture Exchange • TSX-V:PINK • CA71385D1078
ChartMill assigns a Buy % Consensus number of 80% to PINK.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-10 | Raymond James Capital | Initiate | Outperform |
| 2021-12-16 | Raymond James Financial | Initiate | Outperform |
| 2021-11-03 | RJ Financial | Initiate | Outperform |
| 2021-09-24 | Raymond James Financial | Downgrade | Outperform |
| 2021-05-17 | Raymond James Financial | Initiate | Outperform |
| 2021-04-16 | Raymond James Financial | Initiate | Outperform |
| 2021-04-15 | Raymond James Financial | Initiate | Outperform |
| 2021-04-07 | Raymond James Financial | Upgrade | Outperform |
| 2021-03-05 | Raymond James Financial | Initiate | Outperform |
5 analysts have analysed PINK.CA and the average price target is 1.89 CAD. This implies a price increase of 640% is expected in the next year compared to the current price of 0.255.
The consensus rating for PERIMETER MEDICAL IMAGING AI (PINK.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PERIMETER MEDICAL IMAGING AI (PINK.CA) is 5.